Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐<i>versus</i>‐host disease — a real‐world outcomes analysisSameem Abedin, Mehdi Hamadani, Mary Nauffal et al.|British Journal of Haematology|2021Cited by 25
Novel tumor target for antibody-based therapy of rhabdomyosarcoma and other pediatric solid tumorsShakeel Modak, N K Cheung, He Guo et al.|The American journal of pediatric hematology/oncology|2000Cited by 0